Basic and Clinical Immunology Webcast Series
IL-17 and IL12/ IL23 – In Health and Disease
Release date: April 20, 2020
Expiration date: April 20. 2022
Estimated Time of Completion: 15 minutes
Description
The Basic and Clinical Immunology Webcast Series features webcasts by a faculty of experts and summarizes talks presented during the 8th Annual Basic and Clinical Immunology: What Is New and Hot in Immunology Symposium. Designed for busy clinicians who desire to increase their declarative and procedural knowledge in the field of IMIDs, data presented are essential to understanding their clinical application and predicting and preventing toxicity.
IL-17 and IL12/ IL23 – In Health and Disease webcast highlights the basic immunology of IL-12, IL-23 and IL-17.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
Leonard H. Calabrese, DO | Abbvie Pharmaceuticals, BMS, Genentech/Roche, Janssen, Novartis | Consulting Teaching and Speaking |
Crescendo | Teaching and Speaking | |
GSK, Horizon Pharma, Pfizer, Regeneron, Sanofi Aventis, UCB | Consulting |
William Rigby, MD | Abbvie Pharmaceuticals | Consulting Membership on advisory committee or review panels |
Bristol-Myers Squibb Co. | Consulting | |
Genentech/Roche | Consulting Research / Independent Contractor Membership on advisory committee or review panels Teaching and Speaking |
|
Gilead Sciences, Inc. | Consulting Membership on advisory committee or review |
|
Pfizer | Membership on advisory committee or review panels |
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:
AbbVie, Inc.
Bristol-Myers Squibb
Genentech, Inc.
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Live activity from:
AbbVie, Inc.
Bristol-Myers Squibb
Genentech, Inc.
Gilead
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
Pfizer, Inc.
This CME activity was produced by the Cleveland Clinic Center for Continuing Education
and
Cleveland Clinic's RJ Fasenmyer Center for Clinical Immunology.